Document is current
Any future updates will be listed below
-
Authors
Iketani, Sho https://orcid.org/0000-0002-3733-9556
Mohri, Hiroshi https://orcid.org/0000-0003-3101-7625
Culbertson, Bruce https://orcid.org/0000-0002-1489-1348
Hong, Seo Jung
Duan, Yinkai
Luck, Maria I.
Annavajhala, Medini K. https://orcid.org/0000-0002-9229-8849
Guo, Yicheng https://orcid.org/0000-0001-5357-660X
Sheng, Zizhang
Uhlemann, Anne-Catrin https://orcid.org/0000-0002-9798-4768
Goff, Stephen P. https://orcid.org/0000-0002-9679-0582
Sabo, Yosef
Yang, Haitao https://orcid.org/0000-0002-1875-3268
Chavez, Alejandro https://orcid.org/0000-0001-5626-7140
Ho, David D. https://orcid.org/0000-0003-1627-149X
- License Information
-
More Information
Article History
Received: 6 July 2022
Accepted: 2 November 2022
First Online: 9 November 2022
Competing interests
: S.I., A.C. and D.D.H. are inventors on patent applications related to the development of inhibitors against the SARS-CoV-2 3CL protease. D.D.H. is a cofounder of TaiMed Biologics and RenBio, consultant to WuXi Biologics and Brii Biosciences and board director for Vicarious Surgical.
